Skip to content
  • Home
  • About Us
  • Services
    • Drugs and Bioscience
      • Clinical Trial
    • Medical devices
    • Food and beverage
    • Cosmetic Products
    • Employee Training
    • Quality Management System
  • Tobacco Products
    • EU-TPD Notifications
    • FDA-PMTA Application
  • Dietary supplement
    • New Ingredient Notification
  • News
  • Blog
  • Contact us
  • About Us
  • About Us
  • Articles
  • Company’s News
  • Contact us
  • Cosmetic Products
  • Dietary supplement
    • new-dietary-ingredient-notification
  • Drugs and Bioscience
    • Clinical Trial
  • Employee Training
  • Food and beverage
  • Home
  • Home
  • Medical devices
  • Quality Management System
  • Services
  • Tobacco Products
    • EU-TPD Notifications
    • FDA-PMTA Application
Uncategorized

The FDA Authorized the Sales and Marketing of Zyn Nicotine Pouches

JJCC Group / January 17, 2025

The FDA’s authorization for the sale and marketing of Zyn flavored nicotine pouches marks a significant step toward recognizing that […]

Regulation

Remanufacturing of Medical Devices Updated Guidance

JJCC Group / November 14, 2024

Medical devices encompass a vast array of products with different technologies, product lifecycles, complexity, intended users, and environments of use.

Regulation

Transition Plan for Medical Devices That Fall Within Enforcement Policies Issued During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency

JJCC Group / November 14, 2024

FDA plays a critical role in protecting the United States (U.S.) from threats such as emerging infectious diseases, including Coronavirus

Drug's Approval

FDA Approves First Gene Therapy for Treatment of Aromatic L-amino Acid Decarboxylase Deficiency

JJCC Group / November 14, 2024

The U.S. Food and Drug Administration approved Kebilidi (eladocagene exuparvovec-tneq), an adeno-associated virus vector-based gene therapy indicated for the treatment

Compliance Firm Drives Success through Strategic Partnerships
Press

Life Science Regulatory Compliance Firm Delivers Business Success Through Strategic Partnerships

jjccgroup2021 / January 17, 2022

J&JCC Group offers unprecedented success for clients navigating Regulatory Compliance during the COVID-19 Pandemic. Irvine, California, January 12, 2022, J&JCC

FDA Intends to Publish Pathway for CBD Products | J&JCC Group
Regulation

The FDA Intends to Publish a Pathway for CBD Products!

JJCC Group / December 1, 2019

In the letter that the Food and Drugs Administration (FDA) issued on November 25, 2019, the agent issued 15 warning

FDA to Develop New Standards for Safer Tobacco Products
Regulation

FDA Intention to Develop A New Standard for Tobacco Products- Reduced Health Risk!

jjccgroup2021 / August 15, 2018

The Food and Drug Administration (FDA) has recently announced its intention to “explore clear and meaningful measures to make tobacco

Tobacco Products Labeling Compliance Deadline | J&JCC Group
Regulation

Tobacco Products Labeling Compliance. Another Deadline is Approaching – August 10, 2018

jjccgroup2021 / July 28, 2018

Nicotine Addictiveness Warning Statement Beginning August 10, 2018, FDA will enforce a new nicotine warning Statement. Manufacturers and distributors cannot

FDA Demands Additional Information from E-Cigarette Companies
Regulation

FDA requires additional e-cigarette makers to provide critical information so the agency can better examine youth use and product appeal

jjccgroup2021 / May 17, 2018

Summary Letters to four companies follow initial request to JUUL Labs as part of an ongoing effort to address youth

Understanding cGMP Requirements for Tobacco Manufacturers
Regulation

Current Good Manufacturing Practices — An Overlooked Requirement with Far Reaching Consequences

jjccgroup2021 / June 5, 2016

A significant provision of the Family Smoking Prevention and Tobacco Control Act is the requirement for tobacco manufacturers to operate

why us?

Our simple though sophisticated approach strategies ensure timely and cost-effective results.

Industries we Service

  • Dietary supplement
    Pharmaceutical
  • Cosmetic
    Medical devices
    Tobacco /e-cigarette

Contact us

  • 1101 California Ave Suite 100
  • Corona California 92881
[email protected]
1 949 735 6224

Copyright © 2025 | jjccgroup